Current treatment status-Not currently treated - Page 23 of 28 Posts on Medivizor
Navigation Menu

Current treatment status-Not currently treated Posts on Medivizor

Can lymphocyte to monocyte ratio predict outcome following surgery for stage III colon cancer?

Can lymphocyte to monocyte ratio predict outcome following surgery for stage III colon cancer?

Posted by on Jun 14, 2014 in Colorectal cancer | 0 comments

In a nutshell This study evaluated the association between preoperative lymphocyte to monocyte ratio and time to recurrence and overall survival in colon cancer.  Some background Surgery is the principle treatment option for advanced non-metastatic (has not spread to distant organs) colon cancer. 5-fluorouracil-based chemotherapy is the...

Read More

Chemotherapy-induced peripheral neuropathy

Chemotherapy-induced peripheral neuropathy

Posted by on Mar 9, 2014 in Breast cancer | 0 comments

In a nutshell This review explored recent evidence regarding chemotherapy-induced peripheral neuropathy following treatment with different types of chemotherapeutic agents. Some background Chemotherapy, often used in the treatment of cancer, is well-known for its short-term toxic side-effects such as nausea or hair loss. However, symptoms of...

Read More

IGF-R; a new target for prostate cancer treatment?

Posted by on Feb 13, 2014 in Prostate cancer | 0 comments

In a nutshell This review explored the use of insulin-like growth factor receptor blockers as treatment for castration-resistant prostate cancer. Some background Prostate cancer is dependent on androgens, male hormones such as testosterone, for growth. Therefore androgen deprivation therapy, which blocks the production or action of testosterone...

Read More

Multi-parametric magnetic resonance imaging: Is active surveillance right for you?

Multi-parametric magnetic resonance imaging: Is active surveillance right for you?

Posted by on Jan 18, 2014 in Prostate cancer | 0 comments

In a nutshell This study evaluated the use of multi-parametric magnetic resonance imagining (MRI) in the selection of prostate cancer patients for active surveillance. Some background Active surveillance was introduced as a therapeutic strategy to avoid overtreatment of cancer patients with a relatively non-threatening disease. In active...

Read More

A good surgeon makes all the difference

A good surgeon makes all the difference

Posted by on Nov 23, 2013 in Colorectal cancer | 0 comments

In a nutshell This study examined the different factors determining long-term survival following surgery for colorectal cancer. Some background Survival rates among colorectal cancer patients have increased substantially over the past 20 years. Early diagnosis, a deeper understanding of the disease and improvements in treatments and surgical...

Read More

Keeping score on the risk of recurrence

Keeping score on the risk of recurrence

Posted by on Oct 25, 2013 in Breast cancer | 0 comments

In a nutshell This study investigated different scoring scales which could be used to determine the risk of recurrence among estrogen receptor-positive (ER+) breast cancer survivors. Some background Breast cancer survivors are at risk of developing distant recurrence of the cancer even many years after initial cancer treatments. Since usually...

Read More

Recurrence after ablative radiotherapy

Posted by on Oct 1, 2013 in Lung cancer | 0 comments

In a nutshell This study investigated the patterns of cancer recurrence in non small-cell lung cancer (NSCLC) patients treated with stereotactic ablative radiotherapy (SABR). Some background Stereotactic ablative radiotherapy (SABR) is a method of treating early stage, small lung cancer tumors, that cannot be removed by surgery. Like all types of...

Read More